Mirae Asset Global Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $138M | Buy |
2,396,422
+476,894
| +25% | +$27.4M | 0.2% | 71 |
|
|
2026
Q1 | $116M | Sell |
1,919,528
-195,832
| -9% | -$11.4M | 0.04% | 55 |
|
|
2025
Q4 | $114M | Sell |
2,115,360
-96,485
| -4% | -$4.64M | 0.32% | 53 |
|
|
2025
Q3 | $99.8M | Buy |
2,211,845
+93,528
| +4% | +$4.37M | 0.31% | 59 |
|
|
2025
Q2 | $98.1M | Buy |
2,118,317
+454,160
| +27% | +$22.3M | 0.34% | 60 |
|
|
2025
Q1 | $98.2M | Buy |
1,664,157
+97,997
| +6% | +$5.71M | 0.4% | 45 |
|
|
2024
Q4 | $89.1M | Buy |
1,566,160
+172,439
| +12% | +$9.63M | 0.36% | 46 |
|
|
2024
Q3 | $71M | Buy |
1,393,721
+147,246
| +12% | +$6.91M | 0.31% | 62 |
|
|
2024
Q2 | $51.7M | Buy |
1,246,475
+68,723
| +6% | +$3.08M | 0.26% | 72 |
|
|
2024
Q1 | $68.4M | Buy |
1,177,752
+763,213
| +184% | +$38.9M | 0.15% | 138 |
|
|
2023
Q4 | $21.3M | Sell |
414,539
-48,525
| -10% | -$2.55M | 0.04% | 407 |
|
|
2023
Q3 | $26.9M | Buy |
463,064
+13,562
| +3% | +$831K | 0.06% | 324 |
|
|
2023
Q2 | $28.7M | Sell |
449,502
-118,575
| -21% | -$7.95M | 0.06% | 317 |
|
|
2023
Q1 | $39.4M | Buy |
568,077
+42,095
| +8% | +$2.97M | 0.09% | 228 |
|
|
2022
Q4 | $37.8M | Buy |
525,982
+38,827
| +8% | +$2.93M | 0.1% | 226 |
|
|
2022
Q3 | $34.6M | Buy |
487,155
+48,572
| +11% | +$3.52M | 0.09% | 235 |
|
|
2022
Q2 | $33.8M | Buy |
438,583
+70,167
| +19% | +$5.34M | 0.09% | 262 |
|
|
2022
Q1 | $26.9M | Buy |
368,416
+3,300
| +0.9% | +$222K | 0.06% | 356 |
|
|
2021
Q4 | $22.8M | Buy |
365,116
+66,890
| +22% | +$3.92M | 0.05% | 412 |
|
|
2021
Q3 | $17.6M | Buy |
298,226
+44,067
| +17% | +$2.9M | 0.04% | 444 |
|
|
2021
Q2 | $17M | Buy |
254,159
+33,972
| +15% | +$2.22M | 0.05% | 443 |
|
|
2021
Q1 | $13.9M | Sell |
220,187
-94,905
| -30% | -$5.9M | 0.05% | 435 |
|
|
2020
Q4 | $19.5M | Buy |
315,092
+36,007
| +13% | +$2.21M | 0.07% | 320 |
|
|
2020
Q3 | $16.8M | Buy |
279,085
+15,000
| +6% | +$903K | 0.08% | 278 |
|
|
2020
Q2 | $15.5M | Sell |
264,085
-36,327
| -12% | -$2.17M | 0.09% | 246 |
|
|
2020
Q1 | $16.7M | Buy |
300,412
+48,057
| +19% | +$2.94M | 0.13% | 164 |
|
|
2019
Q4 | $16.2M | Buy |
252,355
+22,570
| +10% | +$1.29M | 0.1% | 245 |
|
|
2019
Q3 | $11.7M | Buy |
229,785
+24,984
| +12% | +$1.17M | 0.08% | 274 |
|
|
2019
Q2 | $9.27M | Buy |
204,801
+18,109
| +10% | +$844K | 0.06% | 317 |
|
|
2019
Q1 | $8.92M | Sell |
186,692
-25,273
| -12% | -$1.26M | 0.07% | 290 |
|
|
2018
Q4 | $11M | Sell |
211,965
-25,779
| -11% | -$1.39M | 0.1% | 219 |
|
|
2018
Q3 | $14.8M | Buy |
237,744
+58,445
| +33% | +$3.47M | 0.11% | 189 |
|
|
2018
Q2 | $9.92M | Buy |
179,299
+3,959
| +2% | +$214K | 0.13% | 110 |
|
|
2018
Q1 | $11.1M | Buy |
175,340
+18,028
| +11% | +$1.16M | 0.15% | 104 |
|
|
2017
Q4 | $9.64M | Buy |
157,312
+8,193
| +5% | +$512K | 0.13% | 109 |
|
|
2017
Q3 | $9.48M | Buy |
149,119
+12,695
| +9% | +$741K | 0.17% | 105 |
|
|
2017
Q2 | $7.6M | Buy |
136,424
+8,482
| +7% | +$462K | 0.13% | 116 |
|
|
2017
Q1 | $6.96M | Sell |
127,942
-2,029
| -2% | -$111K | 0.13% | 117 |
|
|
2016
Q4 | $7.6M | Buy |
129,971
+44,501
| +52% | +$2.43M | 0.17% | 108 |
|
|
2016
Q3 | $4.61M | Sell |
85,470
-143,102
| -63% | -$9.19M | 0.1% | 138 |
|
|
2016
Q2 | $16.8M | Buy |
228,572
+4,665
| +2% | +$330K | 0.43% | 57 |
|
|
2016
Q1 | $14.3M | Sell |
223,907
-23,811
| -10% | -$1.5M | 0.39% | 60 |
|
|
2015
Q4 | $17M | Sell |
247,718
-2,359
| -0.9% | -$156K | 0.56% | 45 |
|
|
2015
Q3 | $14.8M | Buy |
250,077
+1,997
| +0.8% | +$127K | 0.61% | 42 |
|
|
2015
Q2 | $16.5M | Sell |
248,080
-31,458
| -11% | -$2.07M | 0.53% | 47 |
|
|
2015
Q1 | $18M | Buy |
279,538
+5,721
| +2% | +$358K | 0.61% | 47 |
|
|
2014
Q4 | $16.2M | Sell |
273,817
-90,746
| -25% | -$5.12M | 0.59% | 56 |
|
|
2014
Q3 | $18.7M | Sell |
364,563
-238,763
| -40% | -$11.9M | 0.67% | 45 |
|
|
2014
Q2 | $29.3M | Sell |
603,326
-9,200
| -2% | -$453K | 0.65% | 42 |
|
|
2014
Q1 | $31.8M | Buy |
612,526
+581,800
| +1,894% | +$31M | 0.81% | 32 |
|
|
2013
Q4 | $1.63M | Buy |
30,726
+674
| +2% | +$34.3K | 0.07% | 196 |
|
|
2013
Q3 | $1.39M | Buy |
30,052
+190
| +0.6% | +$8.34K | 0.06% | 198 |
|
|
2013
Q2 | $1.33M | Buy |
+29,862
| New | +$1.3M | 0.07% | 186 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
AAMU
Mirae Asset Global Investments's BMY Position: Q2 2026 in Review
Mirae Asset Global Investments increased its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, buying an estimated $27.4M and bringing the position to 2,396,422 shares worth $138M. The position accounts for 0.2% of the portfolio, ranked #71.
Mirae Asset Global Investments first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mirae Asset Global Investments held 2,396,422 shares of Bristol-Myers Squibb worth $138M as of Q2 2026.
- Mirae Asset Global Investments bought 476,894 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.4M.
- Bristol-Myers Squibb made up 0.2% of Mirae Asset Global Investments's portfolio in Q2 2026, its #71 holding.
- Mirae Asset Global Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.